Three main mutational pathways in HIV-2 lead to high-level raltegravir and elvitegravir resistance: implications for emerging HIV-2 treatment regimens

Three main mutational pathways in HIV-2 lead to high-level raltegravir and elvitegravir resistance: implications for emerging HIV-2 treatment regimens

Item
http://www.wikidata.org/entity/Q34428902
Effect of HIV-1 integrase resistance mutations when introduced into SIVmac239 on susceptibility to integrase strand transfer inhibitors.Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study.In vitro activity of dolutegravir against wild-type and integrase inhibitor-resistant HIV-2HIV-2 integrase polymorphisms and longitudinal genotypic analysis of HIV-2 infected patients failing a raltegravir-containing regimen.Complex patterns of protease inhibitor resistance among antiretroviral treatment-experienced HIV-2 patients from Senegal: implications for second-line therapy.Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response.Dolutegravir in HIV-2-Infected Patients With Resistant Virus to First-line Integrase Inhibitors From the French Named Patient Program.HIV-2EU-Supporting Standardized HIV-2 Drug-Resistance Interpretation in Europe: An Update.
P2860

Three main mutational pathways in HIV-2 lead to high-level raltegravir and elvitegravir resistance: implications for emerging HIV-2 treatment regimens

Item
http://www.wikidata.org/entity/Q34428902
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Three main mutational pathways ...... rging HIV-2 treatment regimens
@ast
Three main mutational pathways ...... rging HIV-2 treatment regimens
@en
Three main mutational pathways ...... rging HIV-2 treatment regimens
@nl
type
label
Three main mutational pathways ...... rging HIV-2 treatment regimens
@ast
Three main mutational pathways ...... rging HIV-2 treatment regimens
@en
Three main mutational pathways ...... rging HIV-2 treatment regimens
@nl
prefLabel
Three main mutational pathways ...... rging HIV-2 treatment regimens
@ast
Three main mutational pathways ...... rging HIV-2 treatment regimens
@en
Three main mutational pathways ...... rging HIV-2 treatment regimens
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Three main mutational pathways ...... rging HIV-2 treatment regimens
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0045372
P407
P433
P478
P50
P577
P5875
P698
P921
P932